News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Daily News Platelet Hyperreactivity Score May Improve CVD Risk Detection L.A. McKeown August 23, 2024
News Daily News New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients L.A. McKeown August 19, 2024
News Conference News TCT 2023 Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door? L.A. McKeown October 24, 2023
News Daily News FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon L.A. McKeown February 18, 2021
News Conference News AHA 2020 AFFIRM-AHF: IV Iron Supplementation Linked to Fewer Repeat Hospitalizations for HF L.A. McKeown November 13, 2020
News Conference News ACC 2020 VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events L.A. McKeown March 28, 2020
News Conference News VIVA 2018 Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease L.A. McKeown November 15, 2018
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Daily News OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years L.A. McKeown September 23, 2015